We're raising our price target on Cardinal Health after another stellar quarter of profits
The drug distributor also raised its full-year earnings guidance.
Opinion
We're raising our price target on Cardinal Health after another stellar quarter of profits
Grand Herald US session desk (2026-11-05): The drug distributor also raised its full-year earnings guidance. Primary source: original at CNBC Finance (cnbc.com).